Keith Manchester - Nov 9, 2022 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
/s/ Keith Manchester
Stock symbol
ROIV
Transactions as of
Nov 9, 2022
Transactions value $
-$18,631,894
Form type
4
Date filed
11/14/2022, 08:43 PM
Previous filing
Sep 19, 2022
Next filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Other -1.2M -3.01% 38.6M Nov 9, 2022 Held by QVT Financial Investment Cayman Ltd. F1, F2
transaction ROIV Common Shares Sale -$5.19M -1.09M -2.83% $4.75 37.5M Nov 10, 2022 Held by QVT Financial Investment Cayman Ltd. F2
transaction ROIV Common Shares Sale -$1.77M -372K -2.68% $4.75 13.5M Nov 10, 2022 Held by QVT Roiv Hldgs Onshore Ltd. F2
transaction ROIV Common Shares Sale -$11M -2.31M -7.62% $4.75 28M Nov 10, 2022 Held by QVT Deferred Compensation Holdings Ltd. F2
transaction ROIV Common Shares Sale -$694K -146K -2.6% $4.75 5.47M Nov 10, 2022 Held by QVT P&E Roiv Hldgs Ltd. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were distributed in-kind to certain shareholders of QVT Financial Investment Cayman Ltd. who subsequently gifted the shares to charitable foundations, each of which is subject to a lock-up.
F2 The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.